Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma - 07/02/19
Doi : 10.1016/j.jaci.2018.10.011
Heleen Scheerens, PhD a 
, Ashley Smith, BA a, Olga Li, BA a, Lee Honigberg, PhD a, Jeffrey M. Harris, MD, PhD a, Gabriele Holtappels, BS b, Claus Bachert, MD, PhD b, c
, Ashley Smith, BA a, Olga Li, BA a, Lee Honigberg, PhD a, Jeffrey M. Harris, MD, PhD a, Gabriele Holtappels, BS b, Claus Bachert, MD, PhD b, c a Genentech, Inc, South San Francisco, Calif
b Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium
c Division of ENT Diseases, CLINTEC, Karolinska Institute, Stockholm, Sweden
| Genentech, Inc, supported this study and was involved in the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the article for publication. |
|
| Disclosure of potential conflict of interest: H. Scheerens, A. Smith, O. Li, L. Honigberg, and J. M. Harris are currently or were employees of Genentech, Inc, at the time this study was conducted and own Roche stock. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 2
P. 805-807 - février 2019 Retour au numéro
Article précédent
- Validation of the maximum symptom day among children with asthma
- Tianshi David Wu, Matthew Perzanowski, Roger D. Peng, Robert A. Wise, Susan Balcer-Whaley, Michelle Newman, Amparito Cunningham, Wanda Phipatanakul, Elizabeth C. Matsui, Meredith C. McCormack
- Oral exposure to mite allergens: Sensitizer or tolerogenic?
- Mario Sánchez-Borges, Arnaldo Capriles-Hullet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?